Artificial Intelligence-Supported Mobile Application For Diabetes Self-Management

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUludag University

About this trial

Patients in the AI-supported mobile application group will be able to log in with a username and password that will be defined specifically for them. Patients will be informed about how the application is used during their first interview. They will enter their personal and disease characteristics (age, gender, height, weight, HbA1C, HDL, LDL) into the application at the entrance. Other sections of the application will include exercise, nutrition, medication tracking, complication tracking and diabetic foot care sections. The person will be asked to enter relevant information in these fields according to their own life and condition (for example; how many times do you use insulin per day, what are your medication times, how do you spend your day in terms of exercise, how many meals do you eat, what is your diet, do you urinate frequently, are you extremely thirsty, are you hungry often, do you have numbness in your hands and feet, etc.). After the patient enters the necessary information, they will also be asked to enter their daily blood sugar measurement values into the system. Thus, the individual\'s hypo/hyperglycemia risk, risk analysis, nutrition recommendations, medication reminder system, exercise reminder and incentive warnings will be communicated to the individual thanks to the AI-based mobile application. The aim of this application is to reduce the risk of complications and improve the individual\'s quality of life by providing personalized recommendations for all the needs of the individual, including alarms and reminders, and to support patients to continue their diabetes education and disease management more actively.

Eligibility criteria

Qualifiers

Having been diagnosed with diabetes for at least 1 year

Being between the ages of 18-65

Being open to verbal communication

Being able to read and write and speak Turkish

Disqualifiers

Having a perception disorder and psychiatric disorder that prevents the patient from communicating,

Having a condition that prevents them from using a smart phone (advanced retinopathy and neuropathy, internet problems)

Being on intensive insulin treatment

Having a condition that prevents them from continuing the application phase of the study

Trial design

Treatments tested in this trial

  • artificial intelligence-supported mobile application
  • WEB based application

Treatment groups

156 Participants
are divided into 3 treatment groups

Sponsors and collaborators